Rosiglitazone combined with insulin preserves islet β cell function in adult‐onset latent autoimmune diabetes (LADA)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes/Metabolism Research Reviews

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/dmrr.503PMID 15386806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and classification of diabetes mellitus.

  2005cited by this paper
• Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.

  2003cited by this paper
• A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model.

  2003cited by this paper
• Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

  2003cited by this paper
• Latent Autoimmune Diabetes in Adults (LADA)

  2003cited by this paper
• Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis1

  2002cited by this paper
• Peroxisome proliferator‐activated receptor‐γ agonists prevent experimental autoimmune encephalomyelitis

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.

  2002cited by this paper
• Troglitazone Stimulates Pancreatic Growth in Normal Rats

  2002cited by this paper
• Peroxisome Proliferator-Activated Receptor Gamma Agonist Ligands Stimulate a Th2 Cytokine Response and Prevent Acute Colitis

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.

  2002cited by this paper
• Insulin-Sensitizing Agents –Thiazolidinediones (Glitazones)

  2002cited by this paper
• Regulation of Cytokine Expression by Ligands of Peroxisome Proliferator Activated Receptors1

  2002cited by this paper
• Thiazolidinediones for the prevention of diabetes in the non‐obese diabetic (NOD) mouse: implications for human type 1 diabetes

  2002cited by this paper
• Interleukin (IL)-4 Indirectly Suppresses IL-2 Production by Human T Lymphocytes via Peroxisome Proliferator-activated Receptor γ Activated by Macrophage-derived 12/15-Lipoxygenase Ligands*

  2002cited by this paper
• Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment

  2002cited by this paper
• Insulin Intervention to Preserve β Cells in Slowly Progressive Insulin‐Dependent (Type 1) Diabetes Mellitus a

  2002cited by this paper
• Where thiazolidinediones will fit

  2002cited by this paper
• PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease

  2001cited by this paper
• The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis

  2001cited by this paper
• Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands.

  2001cited by this paper
• High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.

  2001cited by this paper
• C-peptide: A new potential in the treatment of diabetic nephropathy

  2001cited by this paper
• Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)

  2001cited by this paper
• Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention.

  2001cited by this paper
• Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma.

  2001cited by this paper
• PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.

  2001cited by this paper
• Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

  2000cited by this paper
• Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells.

  2000cited by this paper
• Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

  2000cited by this paper
• The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses1

  2000cited by this paper
• Activation of Human T Lymphocytes Is Inhibited by Peroxisome Proliferator-activated Receptor γ (PPARγ) Agonists

  2000cited by this paper
• A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

  1999cited by this paper
• T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report.

  1999cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats

  1998cited by this paper
• Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse.

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

  1997cited by this paper
• Small Doses of Subcutaneous Insulin as a Strategy for Preventing Slowly Progressive β-Cell Failure in Islet Cell Antibody—Positive Patients With Clinical Features of NIDDM

  1996cited by this paper
• Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes.

  1995cited by this paper
• A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

  1994cited by this paper
• Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency

  1994cited by this paper
• Detection of GAD65 Antibodies in Diabetes and Other Autoimmune Diseases Using a Simple Radioligand Assay

  1994cited by this paper
• Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of Disease

  1993cited by this paper
• Modulation of antigen expression in relation to intervention strategies in type 1 diabetes.

  1993cited by this paper

• Novel Therapeutic Approach to Preserving or Reversing Pancreatic Islet Beta Cells in Patients With Type 1 Diabetes: A Bayesian Network Meta‐Analysis of Comparative Efficacy

  2026cites this paper
• Treatment-related progression of subclinical atherosclerosis in latent autoimmune diabetes in adults: A two-year longitudinal study.

  2026cites this paper
• Latent autoimmune diabetes in adults: Not type 1, not type 2, a little of both

  2025cites this paper
• Prevalence and Metabolic Profile of Latent Autoimmune Diabetes in Adults LADA in Early-Onset Type 2 Diabetes in South India

  2025cites this paper
• Latent autoimmune diabetes in youth

  2025cites this paper
• Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)

  2024cites this paper
• Type 1 diabetes: A new vision of the disease based on endotypes

  2024cites this paper
• Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version)

  2024cites this paper
• Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy

  2023cites this paper
• Adult-onset autoimmune diabetes

  2022cites this paper
• A Case of Late Diagnosis of Latent Autoimmune Diabetes in Adults

  2022cites this paper
• Atypical Diabetes and Management Considerations.

  2022cites this paper
• Latent autoimmune diabetes in adults in China

  2022cites this paper
• Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy

  2022cites this paper
• Efficacy of Regimens in the Treatment of Latent Autoimmune Diabetes in Adults: A Network Meta-analysis

  2022cites this paper
• Current view of diagnosis and treatment of latent autoimmune diabetes in adults.

  2021cites this paper
• Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report

  2021cites this paper
• Latent Autoimmune Diabetes

  2021cites this paper
• Immunotherapy for type 1 diabetes.

  2021cites this paper
• The role of autoimmunity in the pathophysiology of type 2 diabetes: Looking at the other side of the moon

  2021cites this paper
• Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial

  2021cites this paper
• Latent Autoimmune Diabetes in Adults: The Current Understanding and Challenge

  2021cites this paper
• Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel

  2020cites this paper
• Treating latent autoimmune diabetes in adults in the era of cardiovascular outcomes trials: Old dog should learn new tricks

  2020cites this paper
• L’approccio terapeutico al diabete autoimmune dell’adulto (LADA)

  2020cites this paper
• Therapeutic approaches for latent autoimmune diabetes in adults: One size does not fit all

  2020cites this paper
• Past, present and future of latent autoimmune diabetes in adults

  2020cites this paper
• Latent autoimmune diabetes in adults (LADA)

  2020cites this paper
• Chapter 2 Latent Autoimmune Diabetes in Adults

  2019cites this paper
• Prevalence of Metabolic Syndrome and Its Determinants in Newly-Diagnosed Adult-Onset Diabetes in China: A Multi-Center, Cross-Sectional Survey

  2019cites this paper
• Diabetes Mellitus: A Group of Genetic-Based Metabolic Diseases

  2019cites this paper
• Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management

  2018cites this paper
• Latent Autoimmune Diabetes in Adults

  2018cites this paper
• Latent autoimmune diabetes in adults (LADA) in Asian and European populations

  2017cites this paper
• Latent autoimmune diabetes in adults (LADA)

  2017cites this paper
• Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)

  2017cites this paper
• Adult-onset autoimmune diabetes: current knowledge and implications for management

  2017cites this paper
• Clinical and Biological Characteristics of Patients Aged 65 and Older with Newly Developed Type 1 Diabetes

  2016cites this paper
• Saxagliptin improves glycaemic control and C‐peptide secretion in latent autoimmune diabetes in adults (LADA)

  2016cites this paper
• A Hyperglycemic, Obese and Fast-Weight Losing Adult: A Case Report on Latent Autoimmune Diabetes with Low Anti-Gad65 Titers

  2013cites this paper
• Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms

  2013cites this paper
• [Latent autoimmune diabetes in adults].

  2012cites this paper
• Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy

  2012cites this paper
• Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin

  2012cites this paper
• Interventions for latent autoimmune diabetes (LADA) in adults.

  2011cites this paper
• Diabetes mellitus in Adults - Aspects of Incidence, Autoimmunity and C-peptide

  2011cites this paper
• β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults

  2009cites this paper
• Pioglitazone might prevent the progression of slowly progressive type 1 diabetes.

  2009cites this paper
• Achieve great success, and blaze a trail: review of clinical and basic research progress of Chinese diabetes in the 21st century.

  2009cites this paper
• Protective effects of 1‐α‐hydroxyvitamin D3 on residual β‐cell function in patients with adult‐onset latent autoimmune diabetes (LADA)

  2009cites this paper
• Double diabetes: a mixture of type 1 and type 2 diabetes in youth.

  2009cites this paper
• Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study.

  2009cites this paper
• Diabetes classification: grey zones, sound and smoke: Action LADA 1

  2008cites this paper
• Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazone.

  2008cites this paper
• Latent (slowly progressing) autoimmune diabetes in adults

  2008cites this paper
• [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].

  2008cites this paper
• [Adjunctive therapies to glycaemic control of type 1 diabetes mellitus].

  2008cites this paper
• Diabetes and diarrhea in an elderly woman.

  2008cites this paper
• Drug Class Review: Thiazolidinediones: Final Report Update 1

  2008cites this paper
• Adjuvantes no tratamento da hiperglicemia do diabetes melito tipo 1

  2008cites this paper
• Latent Autoimmune Diabetes in Adults

  2008cites this paper
• Diabetes auto-imune latente do adulto ou diabetes melito tipo 2 magro?

  2008cites this paper
• Diabetes mellitus y síndrome diarreico en mujer de edad avanzada

  2008cites this paper
• Perfil de expressão de genes modulados pela Pioglitazona em ilhotas pancreáticas murídeas

  2008cites this paper
• Efeito da pioglitazona sobre a viabilidade funcional e o índice de apoptose de ilhotas pancreáticas murídeas em cultura

  2008cites this paper
• Randomized, controlled, parallel-group prospective study to investigate the clinical effectiveness of early insulin treatment in patients with latent autoimmune diabetes in adults

  2008cites this paper
• Interventions for latent autoimmune diabetes (LADA) in adults.

  2007cites this paper
• A new expression of diabetes: double diabetes.

  2007cites this paper
• Pramlintide and Other Adjunctive Therapies

  2007cites this paper
• Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization.

  2007cites this paper
• Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths

  2007cites this paper
• Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes.

  2007cites this paper
• Latent autoimmune diabetes in adults: increased awareness will aid diagnosis

  2007cites this paper
• Immunomodulation for the Prevention of SPIDDM and LADA

  2006cites this paper
• Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow.

  2006cites this paper
• Type 1 diabetes and latent autoimmune diabetes in adults.

  2006cites this paper
• Burst of autoimmunity with the emergence of primary Sjogren syndrome, cholestatic autoimmune hepatitis and latent autoimmune diabetes of adults (LADA).

  2006cites this paper
• Treatment of type 2 diabetes

  2006cites this paper
• Small bowel obstruction caused by phytobezoar and associated with vitamin B12 deficiency.

  2006cites this paper
• Treatment of type 2 diabetes. The addition of injection therapy.

  2006cites this paper
• Latent autoimmune diabetes of adults (LADA).

  2006cites this paper
• Interventions for latent autoimmune diabetes in adults (LADA)

  2006cites this paper
• Latent Autoimmune Diabetes in Adults (LADA) - Clinical Features

  year unknowncites this paper